Cash: As of March 31, 2025, Cellectis had $246 million in consolidated cash, cash equivalents, restricted cash and fixed-term deposits classified as current-financial assets. The Company believes its ...

Good afternoon, everyone, and welcome to the Maravai LifeSciences Q1 2025 Results Earnings Call. [Operator Instructions] Also, today's call is being recorded. [Operator Instructions] At this time, ...

Deb Hart; Head, Investor Relations; Maravai LifeSciences Holdings Inc. William Martin; Chief Executive Officer; Maravai LifeSciences Holdings Inc. Kevin Herde; Chief ...